Clinical Trials in Houston

Showing 11181-11200 of 15,366 trials

Oral Margin Spectroscopy Detection Using Optical Spectroscopy

NCT00439205

The goal of this clinical research study is to evaluate an imaging technology that may help clinicians see how far an area of pre-cancerous or cancerous tissue extends in the mouth.

Oral Tumors

M.D. Anderson Cancer Center58 participantsStarted Feb 2007

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00409565

The purpose of this study is to determine if the combination of two new drugs, cetuximab (Erbitux) and bevacizumab (Avastin) can increase the effectiveness of treatment for head and neck cancer. Cetuximab has recently been approved by the FDA for head and neck cancer (that is locally or regionally advanced) when used in combination with radiation therapy. Cetuximab is also approved by the FDA for the treatment of colorectal cancer

Head and Neck CancerSquamous Cell Carcinoma

National Cancer Institute (NCI)48 participantsStarted Sep 2006

Ann Arbor, Michigan, United States • Cleveland, Ohio, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3< 1 mile

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

NCT00056160

Randomized subjects will receive CC-5013 plus high-dose dexamethasone or placebo appearing identical to CC-5013 plus high-dose dexamethasone in 4-week cycles. Each subject will participate in a treatment phase and a follow-up phase.

Multiple Myeloma

Celgene353 participantsStarted Jan 2003

Hoover, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +46 more locations

Oral Margin Spectroscopy Detection Using Optical Spectroscopy

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Find Trials by Condition in Houston

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Improving Teamwork for Neonatal Resuscitation

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Clinical and Genetic Characterization of Individuals With Achromatopsia

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Transversus Abdominis Plane (TAP) Block for Cesarean Section